MedPath

Scalp Nerve Block and Opioid Consumption in Brain Surgery

Phase 4
Completed
Conditions
Brain Tumour
Interventions
Drug: Scalp block with 0.5% plain Marcaine
Drug: Scalp block with 0.9% normal saline
Registration Number
NCT02057367
Lead Sponsor
Chiang Mai University
Brief Summary

Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).

Detailed Description

Anterior scalp block with 0.5% plain Marcaine 20 ml. may reduce the intraoperative opioid consumption in neurosurgical patients who undergoing the supratentorial craniotomy compared to those who receive 0.9% normal saline solution (placebo).

A Prospective Randomized Double Blind Control

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. Patients who have supratentorial brain tumor
  2. Patients have been scheduled to undergo an elective craniotomy to remove tumor in any surgical position
  3. Patients have been general anesthetized with endotracheal intubation and control ventilation
  4. Patients who have provided consent for the participation in the research and for the use of their medical record in research
Exclusion Criteria
  1. Pregnant patients
  2. Patients who have a history of local anesthetic allergy and/ or anaphylaxis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Scalp block with 0.5% plain marcaineScalp block with 0.5% plain MarcaineAnterior scalp block with 0.5% plain Marcaine 20 ml.
Scalp block with 0.9% normal salineScalp block with 0.9% normal salineAnterior scalp block with 0.9% normal saline 20 ml.
Primary Outcome Measures
NameTimeMethod
Intraoperative opioid consumptionDuring the supratentorial craniotomy surgery

The overall intravenous fentanyl consumption (microgram/ kilogram) during the surgery. The decision to administer fentanyl is guided by the changes of blood pressure and/ or heart rate greater than 20% from baseline level.

Secondary Outcome Measures
NameTimeMethod
Heart rate changewithin 5 minutes after skull pin insertion

The maximal heart rate within the first 5 minutes after skull pin insertion will be recorded.

The heart rate change from baseline level will be calculated. The unit is beats per minute.

systolic blood pressure changewithin 5 minutes after skull pin insertion

The maximal systolic blood pressure within the first 5 minutes after skull pin insertion will be recorded.

The systolic blood pressure change from baseline will be calculated. The unit is mmHg.

Trial Locations

Locations (1)

Chiang Mai University

🇹🇭

Chiang Mai, Thailand

© Copyright 2025. All Rights Reserved by MedPath